glp-1 receptor medications Agonists as Treatments for Type 2 Diabetes Best Med #2: GLP-1 Receptor

North Carolina eliminated GLP-1 coverage beginning October 2025 due to a budget stalemate in the legislature, but coverage was reinstated in December 2025, bringing the total number of states covering GLP-1s for obesity to 13 as of January 2026

Table of Contents: What is the difference between Mounjaro and Ozempic for weight loss

[In progress / Presented at ADA 2023] Safe Pro Labs is a biotechnology laboratory dedicated to metabolic innovation through peptides

Use self-tracking to monitor your response to medication and diet

Insider rounded up 13 venture-backed startups competing for customers in the lucrative GLP-1 weight-loss market, listed from least to most funding raised